United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 23, 2026 · Filed Jun 24, 2026

On Jun 23, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$543.95 for US$5.17M under a trading plan, leaving 40,513 shares. Filed Jun 24, 2026 (Form 4).

Sold
9,500 shares
Price
US$543.95 average (US$540.24 to US$546.00)
Value
US$5.17M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 23, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jun 23, 2026Common StockSale299US$540.2449,714Direct
Jun 23, 2026Common StockSale894US$540.9948,820Direct
Jun 23, 2026Common StockSale1,444US$542.1347,376Direct
Jun 23, 2026Common StockSale900US$543.1046,476Direct
Jun 23, 2026Common StockSale1,329US$544.2945,147Direct
Jun 23, 2026Common StockSale3,407US$545.1941,740Direct
Jun 23, 2026Common StockSale1,227US$546.0040,513Direct

Source

View original at SEC

Related